Bookmark

Add to MyYahoo RSS

Merck News

News on Merck (Ticker: MRK) continually updated from thousands of sources around the net.

Yesterday | Value Line

Drug Roundup - " April 17, 2014

There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Teva Pharmaceutical Industries, Merck & Co., Eli Lilly, Bristol Myers Squibb

Yesterday | BioSpace

FDA OKs Merck & Co., Inc. Tablet To Reduce Ragweed Allergies

FDA Approves Merck's RAGWITEKa Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults RAGWITEK is the First and Only FDA Approved Sublingual Allergen Immunotherapy Tablet Indicated for the Treatment of Short Ragweed Pollen Allergies WHITEHOUSE STATION, N.J.-- --Merck , ... (more)

Comment?

Related Topix: Merck & Co., Biotech, Food and Drug Administration, Medicine, Healthcare Industry, Conjunctivitis, Health, Allergy, Immunology, Biology, Science

Yesterday | Freshnews

FDA Approves Merck's RAGWITEKa (Short Ragweed Pollen Allergen...

Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved RAGWITEK Tablet for Sublingual Use .

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Conjunctivitis, Health, Allergy, Immunology, Biology, Science

Thursday | ABC News

FDA OKs Merck Tablet to Reduce Ragweed Allergies

U.S. regulators have again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck & Co., Whitehouse Station, NJ

Thursday | The Papillion Times

FDA OKs Merck tablet to reduce ragweed allergies

Jenkins pleaded guilty in court Wednesday, then refused to accept prosecutors' accounts of the shootings.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Healthcare Industry, Nebraska, Blog News

Thursday | The Miami Herald

FDA OKs Merck tablet to reduce ragweed allergies

U.S. regulators have again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck & Co., Whitehouse Station, NJ

Thursday | Spectroscopy

Udit Batra Appointed Merck Millipore President and CEO

Merck Millipore , the Life Sciences division of Merck, has appointed Udit Batra as President and CEO, responsible for overseeing the organization's worldwide operations effective 15 May 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, World News, Germany, Engineering, Chemical Engineering, Science, Princeton University, University of Delaware, Massachusetts, Massachusetts Government

Wed Apr 16, 2014

Business Journal

Clinipace becomes a 'preferred provider,' starts acting like a big CRO

By reaching a preferred provider deal with a mid-market drug developer, Clinipace is starting to act like a much bigger contract research organization.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, GlaxoSmithKline, Merck & Co.

Wall St. Cheat Sheet

Is Merck a Hot Stock?

The company consists of four operating segments: the Pharmaceutical, Animal Health, Consumer Care, and Alliances segments, and one reportable segment in the Pharmaceutical segment.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

CSRwire.com

Merck Renews Commitment to The Woodmont House at The Children's Inn at NIH

The Children's Inn at NIH today announced a $5 million contribution from the Merck Foundation to support and maintain programs and services at The Inn's Woodmont House, a transitional home for patients who are participating in pediatric research at the National Institutes of Health's Clinical Center.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

The Motley Fool

2 Reasons Why Merck & Co. Is Crushing the Dow

Specifically, the Dow Jones is presently down around 1% on the year. That said, some of its components are still marching northward at a decent clip.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cancer, Health, Healthcare Law, Law, Lung Cancer

This Is London

Reckitt Benckiser may list drugs arm separately

Durex condoms and Nurofen maker Reckitt Benckiser today said its A 1.3 billion drugs business could be split off and listed separately rather than sold outright.

Comment?

Related Topix: Household Products, Reckitt Benckiser, Biotech, Medicine, Healthcare Industry

Tue Apr 15, 2014

KDWN

FDA OKs Merck tablet to reduce grass allergies

Merck & Co. says the Food and Drug Administration has approved its new tablet for grass allergies, Grastek, for patients five to 65 years old.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck & Co., Food and Drug Administration, Whitehouse Station, NJ

The Motley Fool

Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?

Does Merck stand a chance? Merck has lagged the hepatitis C race, but the phase 2 results from its oral combination of MK-5172 and MK-8742 in genotype 1 patients are quite impressive.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Bristol Myers Squibb, Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals

Sys-Con Media

Interim Clinical Study Results, Leadership Appointments, and Earnings ...

Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. , Magellan Health Services Inc. , ABIOMED, Inc. , CONMED Corporation , and Greatbatch, Inc. .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Magellan Health Services, Medical Equipment, ABIOMED, CONMED, Electronics, Wilson Greatbatch Technologies, G&B Solutions

Benzinga

Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings

U.S. stocks rose to start off the holiday-filled shortened trading week on a positive note as investors found plenty of reason to be optimistic on retail sales which jumped the most since 2012.

Comment?

Related Topix: Financial Markets, Life, Holidays, Passover, Startups, Intuitive Surgical, Biotech, Medicine, Healthcare Industry

Mon Apr 14, 2014

SchaeffersResearch.com

Stocks Fight Back on Strong Retail Sales

"This morning, Citigroup Inc reported better-than-expected earnings, and last month's retail sales report came in above the consensus," summarized Schaeffer's Senior Equity Analyst Joe Bell, CMT.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets, Opinion, Day Trading, Personal Finance

Freshnews

FDA Approves Merck's GRASTEK (Timothy Grass Pollen Allergen Extract)...

Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved GRASTEK Tablet for Sublingual Use [2800 Bioequivalent Allergy Units ].

Comment?

Related Topix: Medicine, Pollen, Health, Food and Drug Administration, Biotech, Healthcare Industry, Allergy, Conjunctivitis, Immunology, Biology, Science

Reuters

Merck's grass pollen allergy vaccine wins U.S. approval

Merck & Co Inc said the U.S. Food and Drug Administration on Monday approved its grass pollen allergy vaccine, Grastek, for patients aged 5 to 65. The company, which developed the tablet-based drug with Denmark's ALK Abello, said it expects to launch the treatment in the United States by late April.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration

Pharmaceutical Processing

Pfizer's Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts

Ian C. Read, chairman and CEO of Pfizer, Inc, was elected chairman of the Pharmaceutical Research and Manufacturers of America today at the trade association's annual meeting.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Biogen Idec, Celgene

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••